Clinical Trial Update: Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Isa-Rd (isatuximab plus lenalidomide-dexamethasone) in frail and/or very elderly patients with newly diagnosed multiple myelom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• SARCLISA (isatuximab)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Multiple Myeloma, Cancer | Phase 2 | Status: RECRUITING